JNCE Annual Retained Earnings
-$292.79 M
-$50.92 M-21.05%
31 December 2022
Summary:
As of February 5, 2025, JNCE annual retained earnings is -$292.79 million, with the most recent change of -$50.92 million (-21.05%) on December 31, 2022. During the last 3 years, it has fallen by -$185.63 million (-173.23%).JNCE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JNCE Quarterly Retained Earnings
-$292.79 M
+$50.96 M+14.82%
31 December 2022
Summary:
As of February 5, 2025, JNCE quarterly retained earnings is -$292.79 million, with the most recent change of +$50.96 million (+14.82%) on December 31, 2022. Over the past year, it has dropped by -$50.92 million (-21.05%).JNCE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JNCE Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.1% | -21.1% |
| 3 y3 years | -173.2% | -173.2% |
| 5 y5 years | -226.7% | -226.7% |
JNCE Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +945.5% | +392.3% |
Jounce Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$292.79 M(+21.1%) | -$292.79 M(-14.8%) |
| Sept 2022 | - | -$343.75 M(+9.9%) |
| June 2022 | - | -$312.75 M(+12.0%) |
| Mar 2022 | - | -$279.24 M(+15.4%) |
| Dec 2021 | -$241.87 M(+60.2%) | -$241.87 M(+14.3%) |
| Sept 2021 | - | -$211.64 M(+16.6%) |
| June 2021 | - | -$181.55 M(+2.3%) |
| Mar 2021 | - | -$177.54 M(+17.6%) |
| Dec 2020 | -$151.00 M(+40.9%) | -$151.00 M(-19.0%) |
| Sept 2020 | - | -$186.47 M(+15.4%) |
| June 2020 | - | -$161.57 M(+20.9%) |
| Mar 2020 | - | -$133.60 M(+24.7%) |
| Dec 2019 | -$107.16 M | -$107.16 M(+26.8%) |
| Sept 2019 | - | -$84.49 M(-53.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | -$183.35 M(+4.0%) |
| Mar 2019 | - | -$176.36 M(+7.6%) |
| Dec 2018 | -$163.91 M(+82.9%) | -$163.91 M(+1.3%) |
| Sept 2018 | - | -$161.87 M(+5.0%) |
| June 2018 | - | -$154.23 M(+3.1%) |
| Mar 2018 | - | -$149.56 M(+66.9%) |
| Dec 2017 | -$89.61 M(+22.5%) | -$89.61 M(+11.7%) |
| Sept 2017 | - | -$80.25 M(+5.4%) |
| June 2017 | - | -$76.17 M(+4.6%) |
| Mar 2017 | - | -$72.79 M(-0.5%) |
| Dec 2016 | -$73.17 M(+23.0%) | -$73.17 M(-2.2%) |
| Sept 2016 | - | -$74.84 M(+25.9%) |
| Dec 2015 | -$59.47 M(+112.4%) | -$59.47 M |
| Dec 2014 | -$28.00 M | - |
FAQ
- What is Jounce Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Jounce Therapeutics?
- What is Jounce Therapeutics annual retained earnings year-on-year change?
- What is Jounce Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Jounce Therapeutics?
- What is Jounce Therapeutics quarterly retained earnings year-on-year change?
What is Jounce Therapeutics annual retained earnings?
The current annual retained earnings of JNCE is -$292.79 M
What is the all time high annual retained earnings for Jounce Therapeutics?
Jounce Therapeutics all-time high annual retained earnings is -$28.00 M
What is Jounce Therapeutics annual retained earnings year-on-year change?
Over the past year, JNCE annual retained earnings has changed by -$50.92 M (-21.05%)
What is Jounce Therapeutics quarterly retained earnings?
The current quarterly retained earnings of JNCE is -$292.79 M
What is the all time high quarterly retained earnings for Jounce Therapeutics?
Jounce Therapeutics all-time high quarterly retained earnings is -$59.47 M
What is Jounce Therapeutics quarterly retained earnings year-on-year change?
Over the past year, JNCE quarterly retained earnings has changed by -$50.92 M (-21.05%)